Advances in the screening and treatment of ovarian cancer.
Ovarian cancer is the leading cause of death from gynecologic malignancies. This article reviews the newer chemotherapeutic agents and treatment strategies available to the practicing clinician. Also discussed are the benefits and shortfalls of the various options for screening, such as ultrasound and tumor markers, as well as the data supporting oral contraceptives and the controversy surrounding prophylactic oophorectomy.
Runowicz
C D
CD
Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, Bronx, New York.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D012307:Risk Factors; D014463:Ultrasonography
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D007155:Immunologic Factors